查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1308687

到 2030 年全球血糖监测市场预测 - 按类型、技术、应用、最终用户和地区进行分析

Blood Glucose Test Strips Market Forecasts to 2030 - Global Analysis By Type, Technology (Glucose Dehydrogenase and Glucose Oxidase ), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

据Stratistics MRC预计，2023年全球血糖监测条市场规模将达到144.1亿美元，预计预测期内復合年增长率为8.2%，到2030年达到250.2亿美元。

薄纸或塑料条（称为血糖条）用于检查血糖水平和管理糖尿病。这些试纸条上涂有葡萄糖氧化□，它与血液中的葡萄糖发生反应，从而显示血糖水平。糖尿病患者可以定期监测血糖，而无需去诊所或诊断实验室。血糖试纸价格实惠，使用方便，适合日常使用。

据国际糖尿病联盟（IDF）预测，2021年成人糖尿病患者人数约为5.37亿，预计2030年将增加6.43亿。

市场动态：

促进者

个人可支配收入增加

糖尿病患病率的上升是预计推动全球血糖监测条市场增长的主要因素之一。患者更喜欢使用个人血糖仪，因为它们易于使用。糖尿病患者的长期健康和慢性糖尿病并发症的一级预防都依赖于严格的血糖控制。指导糖尿病患者如何将每日毛细血管血糖水平控制在所需范围内。医生经常使用血糖仪来监测危重病人，糖尿病患者也经常使用血糖仪来自我管理疾病。血糖仪也在不断改进，使其更易于使用、更有效。

制约因素：

缺乏意识

血糖试纸市场可能会面临诸如患者不了解改进试纸的好处、临床需求未得到满足以及缺乏外部资金等挑战，所有这些都可能会阻碍增长，特别是在新兴市场，从而限制市场扩张。

机会：

医疗保健支出增加和城市化进程加快

血糖试纸比人工胰腺系统更可靠、更便宜，儘管取得了许多技术突破，但仍在使用。预计有助于全球血糖试纸市场增长的其他因素包括医疗保健成本上升、人口老龄化、消费者对血糖试纸意识的提高、政府举措的增加以及新兴经济体日本可支配收入的增加。此外，由于城市化进程的加快以及久坐生活方式的人口不断增加，预计该市场将会增长。

威胁

成本高、监管严格

严格的监管要求可能会阻碍增长，而高昂的治疗成本预计将在预测期内严重限制血糖监测条的市场扩张。此外，与更传统的葡萄糖测试方法相比，由于设备成本较高，预计市场将面临挑战。

COVID-19 的影响：

在 COVID-19 大流行期间，血糖监测设备的使用有所增加，这影响了对试纸的需求。COVID-19大流行期间，血糖监测设备和试纸等耗材的需求和在线销售大幅增加。这可能是由于对患者和普通人群持续监测血糖水平的需求不断增长，以记录感染后症状并作为预防措施，从而推动市场增长。

预计 2 型糖尿病细分市场在预测期内将是最大的细分市场：

预计 2 型糖尿病细分市场将在预测期内获得较大的市场份额。2 型糖尿病患者必须监测血糖水平，以防止进一步的并发症，因为久坐的生活方式导致他们的血糖水平不受控制。根据美国疾病控制与预防中心 (CDC) 的数据，2 型糖尿病占成人诊断糖尿病病例的 90-95%。近 10% 的女性在产后不久就被诊断出患有 2 型糖尿病，其余女性则在 10-20 年后以 35-60% 的机率患上 2 型糖尿病。由于上述因素，全球范围内对血糖试纸的需求大幅增加。

预计医院领域在预测期内復合年增长率最高：

预计医院部门在预测期内将呈现最高增长率。在医院使用血糖仪套件可以减少办公时间，因为这些测试比传统的实验室测试更快地提供结果。SMBG 装置是一种侵入性较小、痛苦较小的手术，特别是对于不喜欢注射器静脉穿刺或有恐血症的患者。此外，一些患者更愿意去医院由合格的医疗专业人员检查血糖水平，这种偏好正在推动这一市场的扩张。

占比最大的地区：

由于注重健康的人口比例较高且医疗保健行业完善，预计北美地区将占据较大的市场份额。在北美，由于政府积极努力抗击糖尿病以及企业投资提高糖尿病研发效率，预计未来增长。目前北美有超过 2900 万糖尿病患者，预计到 2025 年这一数字将增至 3200 万。此外，该地区重要市场参与者的存在是预测期内北美血糖监测条市场增长的主要驱动力。

复合年增长率最高的地区：

由于对有效治疗的需求不断增长，预计亚太地区在预测期内将成为血糖监测条的新兴市场。这一增长主要是由于该地区糖尿病患病率迅速上升，预计到 2030 年印度将出现 9290 万例糖尿病。此外，该地区不断增长的糖尿病人口以及人们对糖尿病管理意识的不断增强也推动了这一增长。

重大发展

2022 年 11 月，全球糖尿病护理公司、CONTOUR(R) 血糖监测 (BGM) 系统的投资组合製造商和 Eversense(R) 连续血糖监测 (CGM) 系统的经销商 Ascensia Diabetes Care 宣布 Eversense(R) CGM 应用程序已在全球范围内更新，可与Apple HealthTM 无缝集成。使用 Eversense CGM 系统的糖尿病患者现在可以在 Apple Health 应用程序中查看他们的血糖数据，以及来自 iPhone 上流行的健康和福祉平台的其他健康指标。

2022 年11 月，Senseonics 和Ascensia 宣布设立一名护士，旨在通过为Eversense(R) E3 连续血糖监测系统(CGM) 提供办公室和家庭插入选项来扩大患者接触范围。 □宣布与Practitioner Group 建立合作伙伴关係。

2022 年 3 月，加拿大卫生部宣布对健康网络系统 (HNS) 关于安大略省药物福利 (ODB) 计划中血糖试纸报销的变更。HNS 将根据符合 ODB 资格的患者提交的在线索赔和文件，对血糖试纸实行年度最大数量限制。

报告内容

  • 区域和国家层面的市场份额评估
  • 对新进入者的战略建议
  • 涵盖2021年、2022年、2023年、2026年和2030年的市场数据
  • 市场趋势（市场驱动因素/制约因素/机会/威胁/挑战/投资机会/建议）
  • 根据市场预测提出关键业务领域的战略建议
  • 竞争格局映射关键共同趋势
  • 公司概况，包括详细战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制服务：

订阅此报告的客户将获得以下免费定制选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要公司的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（注：通过可行性检查）
  • 竞争标桿
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

目录

第一章内容提要

第二章前言

  • 概述
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源

第三章市场趋势分析

  • 促进者
  • 抑製剂
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5 全球血糖试纸市场，按类型

  • 厚电化学膜
  • 薄膜电化学
  • 灯带
  • 其他类型

6.按技术划分的全球血糖试纸市场

  • 葡萄糖脱氢□（GDH）
  • 葡萄糖氧化□（GOD）

7 全球血糖试纸市场，按应用

  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 糖尿病前期

8 全球血糖试纸市场，按最终用户划分

  • 个人
  • 医院
  • 诊所和诊断中心
  • 其他最终用户

9.全球血糖试纸市场，按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲

第 10 章主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章公司简介

  • Abbott Diabetes Care.
  • ACON Laboratories Inc.
  • Agamatrix Inc.
  • Arkray Inc.
  • Ascensia Diabetes Care
  • Bayer Diabetes Care
  • Bionime Corporation
  • Elektronika
  • i-SENS
  • Johnson & Johnson
  • LifeScan IP Holdings LLC
  • Nipro Diagnostics
  • Roche Diagnostics
  • Rossmax International Ltd
  • TaiDoc
  • Trividia Health Inc.
  • Universal Biosensors
Product Code: SMRC23387

According to Stratistics MRC, the Global Blood Glucose Test Strips Market is accounted for $14.41 billion in 2023 and is expected to reach $25.02 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Thin paper or plastic strips called blood glucose test strips are used to check blood glucose levels and help manage diabetes. The strips are covered in glucose oxidase, which reacts with the blood's glucose to reveal the blood sugar level. These are used by diabetics to monitor their blood glucose levels on a regular basis without having to go to a clinic or a diagnostic lab. In addition, blood glucose test strips are affordable, simple to use, and suitable for daily use.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, which is expected to increase by 643 million in 2030.

Market Dynamics:

Driver:

Rising personal disposable income

The rising prevalence of diabetes is one of the main factors anticipated to propel market growth for blood glucose test strips worldwide. Patients prefer to use glucometers for personal use because they are simple to use. The long-term health of diabetics and the primary prevention of chronic diabetic complications both depend on strict glucose control. Patients with diabetes are taught how to manage their daily capillary glucose levels in order to keep them within desired ranges. Blood glucose meters are frequently used by doctors to monitor critically ill patients as well as by diabetic patients to self-manage their disease. Glucometers are also continually upgraded for easier use and greater effectiveness.

Restraint:

Lack of awareness

The blood glucose test strip market is likely to face challenges due to patient ignorance of the benefits of improved test strips, unmet clinical needs, and a lack of external funding, which are all limiting market expansion, particularly in developing nations.

Opportunity:

Increasing healthcare expenditure and growing urbanization

Blood glucose test strips are still used as they are more reliable and affordable than artificial pancreas systems, despite numerous groundbreaking technological developments that are focused on them. Other factors that are anticipated to contribute to the growth of the global blood glucose test strips market include rising healthcare costs, an aging population, increased consumer awareness of blood glucose test strips, increased government initiatives, and rising disposable income in emerging economies. Additionally, the market is expected to grow as a result of increasing urbanization and an ever-growing population that is leading a more sedentary lifestyle.

Threat:

High costs and strict regulations

Strict regulatory requirements could impede growth, and high treatment costs are anticipated to limit market expansion for blood glucose test strips to a large extent during the forecast period. Additionally, the market is anticipated to face challenges due to the high cost of the device when compared to more traditional glucose testing methods.

COVID-19 Impact:

The use of blood glucose monitoring equipment has increased during the COVID-19 pandemic, which has affected the demand for test strips. During the COVID-19 pandemic, the demand for and online sales of blood glucose monitoring equipment and supplies, such as test strips, significantly increased. This can be attributed to the rising demand for continuous monitoring of sugar levels in patients and the general population in order to record post-infection symptoms and act as a preventative measure, which is augmenting market growth.

The type 2 diabetes segment is expected to be the largest during the forecast period:

During the anticipated period, the type 2 diabetes segment is anticipated to gain significant market share. Patients with Type-2 diabetes must monitor their blood sugar levels to prevent further complications because their blood glucose levels are out of control as a result of their sedentary lifestyles. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes makes up 90 to 95% of all diagnosed cases of diabetes in adults. Nearly 10% of women have type 2 diabetes identified soon after birth; the remaining women have a 35 to 60% chance of developing the disease over the following 10 to 20 years. The aforementioned factor's has led to a significant increase in blood glucose test strip demand worldwide.

The hospitals segment is expected to have the highest CAGR during the forecast period:

The hospitals segment is anticipated to witness the highest growth rate during the forecasted period. Since these tests yield results more quickly than traditional laboratory tests, the use of glucose meter kits in hospitals speeds up operational times. SMBG devices are a convenient method, especially for patients who prefer not to use venipuncture methods through syringes or who have hemophobia, as they are minimally invasive and less painful for patients. Additionally, some patients favor visiting hospitals to have their blood sugar levels checked by qualified medical professionals, and this preference is fueling the expansion of this market.

Region with largest share:

Owing to its large proportion of health-conscious people and established healthcare industry, the North American region is anticipated to hold a significant market share. North America has a lot of potential for growth in the future due to increased government efforts to combat diabetes and corporate investments to streamline diabetes R&D. In North America, there are currently over 29 million diabetics, and by 2025, that number is expected to rise to 32 million. Additionally, the presence of significant market players in the area has been a major driver of the growth of the blood glucose test strip market in North America over the forecast period.

Region with highest CAGR:

Due to the region's increasing need for efficient therapeutic treatment, Asia Pacific is anticipated to be an emerging market for blood glucose test strips during the forecasted period. This growth is primarily the result of the rapidly rising prevalence of diabetes in the area; by 2030, India is expected to have 92.9 million cases. Additionally, the growth is being fueled by the region's rising diabetic population and growing awareness of diabetes management.

Key players in the market

Some of the key players profiled in the Blood Glucose Test Strips Market include Abbott Diabetes Care, ACON Laboratories Inc., Agamatrix Inc., Arkray Inc., Ascensia Diabetes Care, Bayer Diabetes Care, Bionime Corporation, Elektronika, i-SENS, Johnson & Johnson, LifeScan IP Holdings LLC, Nipro Diagnostics, Roche Diagnostics, Rossmax International Ltd, TaiDoc, Trividia Health Inc. and Universal Biosensors.

Key Developments:

In November 2022, Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and distributor of the Eversense® Continuous Glucose Monitoring (CGM) System, announces that the Eversense® CGM app has been updated globally to seamlessly integrate with Apple HealthTM. This means that people with diabetes using Eversense CGM Systems will now also have the option to view their glucose data within the Apple Health app, alongside other health metrics on the iPhone's widely used health and wellbeing platform.

In November 2022, Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM).

In March 2022, Ministry of Health Canada released Health Network System (HNS) changes to reimbursement of blood glucose test strips under the Ontario Drug Benefit (ODB) Program. The HNS will apply the blood glucose test strip's annual maximum quantity limit based on online claims and papers submitted for reimbursement by ODB-eligible patients.

Types Covered:

  • Thick Film Electrochemical Films
  • Thin Film Electrochemical
  • Optical Strips
  • Other Types

Technologies Covered:

  • Glucose Dehydrogenase (GDH)
  • Glucose Oxidase (GOD)

Applications Covered:

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Pre-Diabetes

End Users Covered:

  • Individuals
  • Hospitals
  • Clinics & Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blood Glucose Test Strips Market, By Type

  • 5.1 Introduction
  • 5.2 Thick Film Electrochemical Films
  • 5.3 Thin Film Electrochemical
  • 5.4 Optical Strips
  • 5.5 Other Types

6 Global Blood Glucose Test Strips Market, By Technology

  • 6.1 Introduction
  • 6.2 Glucose Dehydrogenase (GDH)
  • 6.3 Glucose Oxidase (GOD)

7 Global Blood Glucose Test Strips Market, By Application

  • 7.1 Introduction
  • 7.2 Type 1 Diabetes
  • 7.3 Type 2 Diabetes
  • 7.4 Gestational Diabetes
  • 7.5 Pre-Diabetes

8 Global Blood Glucose Test Strips Market, By End User

  • 8.1 Introduction
  • 8.2 Individuals
  • 8.3 Hospitals
  • 8.4 Clinics & Diagnostic Centers
  • 8.5 Other End Users

9 Global Blood Glucose Test Strips Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Diabetes Care.
  • 11.2 ACON Laboratories Inc.
  • 11.3 Agamatrix Inc.
  • 11.4 Arkray Inc.
  • 11.5 Ascensia Diabetes Care
  • 11.6 Bayer Diabetes Care
  • 11.7 Bionime Corporation
  • 11.8 Elektronika
  • 11.9 i-SENS
  • 11.10 Johnson & Johnson
  • 11.11 LifeScan IP Holdings LLC
  • 11.12 Nipro Diagnostics
  • 11.13 Roche Diagnostics
  • 11.14 Rossmax International Ltd
  • 11.15 TaiDoc
  • 11.16 Trividia Health Inc.
  • 11.17 Universal Biosensors

List of Tables

  • Table 1 Global Blood Glucose Test Strips Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 4 Global Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 5 Global Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 6 Global Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 8 Global Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 9 Global Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 10 Global Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 12 Global Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 13 Global Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 14 Global Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 15 Global Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 17 Global Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 19 Global Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 20 North America Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 22 North America Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 23 North America Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 24 North America Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 25 North America Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 North America Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 28 North America Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 29 North America Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 North America Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 31 North America Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 32 North America Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 33 North America Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 34 North America Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 North America Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 36 North America Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 North America Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 38 North America Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 39 Europe Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 41 Europe Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 42 Europe Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 43 Europe Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 44 Europe Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 45 Europe Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 46 Europe Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 47 Europe Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 48 Europe Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 49 Europe Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 50 Europe Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 51 Europe Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 52 Europe Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 53 Europe Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Europe Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 55 Europe Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 56 Europe Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 57 Europe Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 58 Asia Pacific Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 60 Asia Pacific Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 61 Asia Pacific Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 62 Asia Pacific Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 63 Asia Pacific Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 64 Asia Pacific Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 65 Asia Pacific Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 66 Asia Pacific Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 67 Asia Pacific Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 68 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 69 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 70 Asia Pacific Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 71 Asia Pacific Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 72 Asia Pacific Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 Asia Pacific Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 74 Asia Pacific Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 Asia Pacific Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 76 Asia Pacific Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 77 South America Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 79 South America Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 80 South America Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 81 South America Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 82 South America Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 83 South America Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 84 South America Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 85 South America Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 86 South America Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 87 South America Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 88 South America Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 89 South America Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 90 South America Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 91 South America Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 South America Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 93 South America Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 South America Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 95 South America Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 96 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 98 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 99 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 100 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 101 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 102 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 103 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 104 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 105 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 106 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 108 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 109 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 110 Middle East & Africa Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 112 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 113 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 114 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)